Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2008-03-17
2011-12-27
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085500, C424S085600, C424S085700
Reexamination Certificate
active
08084022
ABSTRACT:
The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biological activity, and reducing or preventing fibrillar formation of a peptide, polypeptide, or variant thereof, for example interferons, such as interferon-alpha, interferon-beta, interferon-gamma, and variants thereof.
REFERENCES:
patent: 4130709 (1978-12-01), Nagarajan
patent: 4440675 (1984-04-01), Braude
patent: 5122187 (1992-06-01), Schwarz et al.
patent: 5198420 (1993-03-01), Donahoe et al.
patent: 5369095 (1994-11-01), Kee et al.
patent: 5556757 (1996-09-01), Alstyne et al.
patent: 5661130 (1997-08-01), Meezan et al.
patent: 5849704 (1998-12-01), Sorensen et al.
patent: 6017883 (2000-01-01), Cooper, Jr.
patent: 6524557 (2003-02-01), Backstrom et al.
patent: 7186691 (2007-03-01), Quay et al.
patent: 7425542 (2008-09-01), Maggio
patent: 2002/0110524 (2002-08-01), Cowan et al.
patent: 2004/0209814 (2004-10-01), Nauck
patent: 2004/0258663 (2004-12-01), Quay et al.
patent: 2005/0031549 (2005-02-01), Quay et al.
patent: 2005/0215475 (2005-09-01), Ong et al.
patent: 2005/0276843 (2005-12-01), Quay et al.
patent: 2006/0046962 (2006-03-01), Meezan et al.
patent: 2006/0074025 (2006-04-01), Quay et al.
patent: 2006/0183674 (2006-08-01), Brand et al.
patent: 2007/0111938 (2007-05-01), Pert
patent: 2008/0194461 (2008-08-01), Maggio
patent: 2008/0268032 (2008-10-01), Maggio
patent: 2009/0047347 (2009-02-01), Maggio
patent: 2009/0156478 (2009-06-01), Lau et al.
patent: 2009/0326193 (2009-12-01), Maggio et al.
patent: WO 9933853 (1999-07-01), None
patent: WO 2006/025882 (2006-03-01), None
patent: WO 2006/025882 (2006-03-01), None
patent: WO 2006/051110 (2006-05-01), None
patent: WO 2006/051110 (2006-05-01), None
van der Lubben et al. Chitosan and its derivatives in mucosal drug and vaccine delivery. European Journal of Pharmaceutical Sciences. 2001, vol. 14, pp. 201-207.
Ahsan, F. et al., “Enhanced Bioavailability of Calcitonin Formulated with Alkylglycosides following Nasal and Ocular Administration in Rats,”Pharmaceutical Research, vol. 18, pp. 1742-1746, 2001.
Arnold, John J. et al., “Correlation of Tetradecylmaltoside Induced Increases in Nasal Peptide Drug Delivery with Morphological Changes in Nasal Epithelial Cells,”Journal of Pharmaceutical Sciences, vol. 93, pp. 2205-2213, 2004.
Bagger et al., “Nasal Bioavailability of Peptide T in Rabbits: Absorption Enhancement by Sodium Glycocholate and Glycofurol,”European Journal of Pharmaceutical Sciences, vol. 14, pp. 69-74, 2001.
Pillion et al., “Insulin Delivery in Nosedrops: New Formulations Containing Alkylglycosides,”Endocrinology, vol. 135(6), pp. 2386-2391, 1994.
Rosevear et al., “Alkyl Glycoside Detergents: A Simpler Synthesis and Their Effects on Kinetic and Physical Properties of CytochromecOxidase,”Biochemistry, vol. 19, pp. 4108-4115, 1980.
Hovgaard et al., “Stabilization of insulin by alkylmaltosides. A. Spectroscopic evaluation”, International Journal of Pharmaceutics, 132(1-2):107-113 (1996).
Hovgaard et al., “Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in rats”, International Journal of Pharmaceutics, 132(1-2):115-121 (1996).
van der Lubben et al., “Chitosan and its derivatives in mucosal drug and vaccine delivery”, Eur. J. Pharm. Sci., 14(3):201-207 (2001).
Mitrano & Newton, “Factors affecting insulin adherence to type I glass bottles”,Am. J. Hosp. Pharm., 39(9):1491-5 (1982).
Aegis Therapeutics, LLC
DLA Piper (LLP) US
Russel Jeffrey E
LandOfFree
Stabilizing alkylglycoside compositions and methods thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilizing alkylglycoside compositions and methods thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilizing alkylglycoside compositions and methods thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4299692